
Development of a single drug, whether it is a new chemical entity or a biological therapeutic, requires significant investment of resources. Each step of the process from early discovery through production and delivery must be fully explored, characterized, and understood. Enzo Life Sciences offers a unique set of assays that provide solutions for biotherapeutic characterization, aggregate detection, and contaminant detection for optimizing process development, formulation, in-house QC testing, lot-to-lot reproducibility, and more. Our aim is to deliver tools that make drug development more efficient, more cost-effective, and more successful.
Sensitive ELISA kits for measuring PEGylated Proteins and detecting residual Protein A contaminant.

ProteoStat® dye-based aggregation assays for quantifying aggregates and optimizing formulation.

Reliable custom assay development based on industry-proven design and manufacturing capabilities.

The Direct Selection of Hybridomas (DiSH™) kit offers improved efficiency for detection of high-specificity mAbs.
Optimizing Biologics Formulations : Quantifying Trace
Subvisible Protein Aggregates Using a Protein
Aggregation Assay and Standards.”
Wayne F. Patton, Ph.D.
Read the tutorial